Stifel | Jotup

Revolution Medicines to Participate in Upcoming Investor Conferences

Retrieved on:

Thursday, April 4, 2024

Stifel, Patient, Webcast, Conference, Revolution

REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be a featured speaker at the 23rd Annual Needham Healthcare Conference and the Stifel Targeted Oncology Forum.

Key Points:

REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be a featured speaker at the 23rd Annual Needham Healthcare Conference and the Stifel Targeted Oncology Forum.
Details of the company’s participation are as follows:
To access the live webcasts of the Needham and Stifel fireside chats, please visit the “Events & Presentations” page of Revolution Medicines’ website at https://ir.revmed.com/events-and-presentations .
Additionally, a replay of each webcast will be available on the “Events & Presentations” page of the Revolution Medicines website for at least 14 days following the conference.

Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction

Retrieved on:

Tuesday, April 2, 2024

Stifel, Tiger, Sale, Berkeley Research Group, Acquisition, Blank Rome, United States bankruptcy court, Bankruptcy, Breast, Regenerative medicine, Hearing, Kirkland & Ellis, Kirkland, Insurance

IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (“Sientra” or the “Company”) announced that, following the completion of its Section 363 sales auction, Tiger Aesthetics Medical, LLC (“Tiger”) has been declared the successful bidder for certain of the assets of Sientra used in its breast reconstruction and augmentation business. As consideration for the acquisition, Tiger will pay a cash consideration of $42.5 million as well as assume certain liabilities of the Company, including up to $7 million in cure costs for certain assumed contracts, all the Company’s warranties for breast implants sold prior to the closing date, and all of the Company’s customer contracts.

Key Points:

IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (“Sientra” or the “Company”) announced that, following the completion of its Section 363 sales auction, Tiger Aesthetics Medical, LLC (“Tiger”) has been declared the successful bidder for certain of the assets of Sientra used in its breast reconstruction and augmentation business.
Sientra also announced that it has entered into a definitive agreement with Nuance Intermediary, LLC (“Nuance”), pursuant to which Nuance will acquire substantially all the assets of Sientra used in its BIOCORNEUM business.
Tiger Aesthetics Medical, LLC is represented by Blank Rome LLP as legal counsel and H.C. Wainwright & Co. as investment banker.
Nuance Intermediary, LLC, an investment of Nuance Holdings LLC, as well as the owner of Nuance Medical, is represented by Ferguson Braswell Fraser Kubasta PC as legal counsel.

Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement

Retrieved on:

Thursday, March 28, 2024

Stifel, BB Biotech, Exchange, Sale, Cancer, Security (finance), Therapy

The financing is being led by existing investor BVF Partners L.P. and includes existing investors BB Biotech AG and Santé, and other leading institutional investors.

Key Points:

The financing is being led by existing investor BVF Partners L.P. and includes existing investors BB Biotech AG and Santé, and other leading institutional investors.
The closing of the second tranche is subject to the satisfaction of customary closing conditions.
MTEM intends to use the net proceeds from the proceeds of the second tranche to fund its ongoing clinical studies, working capital and for general corporate purposes.
MTEM has agreed to file a resale registration statement with the Securities and Exchange Commission registering the resale of the securities issued in the second tranche.

CSI Customer Conference Returns With Keynote Speaker Tim Tebow

Retrieved on:

Tuesday, April 9, 2024

CSI , a leading provider of end-to-end financial software and technology, will hold its 2024 customer conference, titled CX24: Authentic Roots, Ambitious Pursuits, from April 14 to April 17 in San Antonio.

Key Points:

CSI , a leading provider of end-to-end financial software and technology, will hold its 2024 customer conference, titled CX24: Authentic Roots, Ambitious Pursuits, from April 14 to April 17 in San Antonio.
David Culbertson, CSI’s president and CEO, will open the conference with his keynote speech, featuring the latest news from CSI, his vision for the company’s future and insight into today’s community banking industry.
“The integrity and authenticity of customer relationships are the heart of community banking—and the key to creating lifelong account holders.
For more information on the customer-only conference, including a list of breakout sessions, visit the CX24 website .

Sensorion Announces a €15 Million Financing, Extending Cash Runway Until the End of 2025

Retrieved on:

Monday, April 8, 2024

The settlement-delivery of the Reserved Offering is expected to take place around April 11, 2024, subject to customary conditions.

Key Points:

The settlement-delivery of the Reserved Offering is expected to take place around April 11, 2024, subject to customary conditions.
This builds on the earlier EUR 50 million financing announced in February 2024, adding up to a total of EUR 100 million raised in less than 9 months.
The capital increase enables the Company to finance its activities until the end of 2025.
Leerink Partners LLC (“Leerink Partners”) and Stifel Europe AG (“Stifel”) are acting as lead agents in connection with the Reserved Offering.

Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing

Retrieved on:

Wednesday, March 13, 2024

SVB Securities, Stifel, Common stock, Novo Holdings A/S, Sale, Public expenditure, Prospectus, Therapy, Security (finance)

Lexeo sold 6,278,905 shares of its common stock (“Common Stock”) in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), at a sale price equal to $15.13 per share.

Key Points:

Lexeo sold 6,278,905 shares of its common stock (“Common Stock”) in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), at a sale price equal to $15.13 per share.
Lexeo intends to use net proceeds from the financing to fund advancement of ongoing clinical stage programs, and for working capital and general corporate purposes.
The proceeds from this financing, combined with current cash, cash equivalents and marketable securities, are expected to fund operating and capital expenditures into 2027.
Any offering of the shares sold in the private placement under the Resale Registration Statement will only be made by means of a prospectus.

Dubin Clark Completes Sale of Platform Company PEAK Event Services to Bright Event Rentals

Retrieved on:

Tuesday, March 19, 2024

Small Business, Professional Services, Finance, Stifel, Partnership, Acquisition, Trivest, History, Growth, PEAK, Video game

Dubin Clark, a private equity firm focused on building niche market leaders in the lower middle market, announced today that it has sold portfolio company PEAK Event Services (the “Company”) to Bright Event Rentals, a portfolio company of Trivest Partners.

Key Points:

Dubin Clark, a private equity firm focused on building niche market leaders in the lower middle market, announced today that it has sold portfolio company PEAK Event Services (the “Company”) to Bright Event Rentals, a portfolio company of Trivest Partners.
PEAK Event Services is one of the largest party and event rental businesses in the country.
PEAK provides rental services that include a deep, diversified inventory of party & event equipment, traditional & boutique table linens, and expert tenting services.
Dubin Clark recapitalized PEAK in partnership with the company in November 2014 and subsequently led the acquisition of six add-ons to build scale, service offerings, and geographic reach.

Vistagen to Present at Stifel 2024 Virtual CNS Days

Retrieved on:

Monday, March 11, 2024

Professional Services, Mental Health, Health, Neurology, Finance, Pharmaceutical, Biotechnology, Stifel, Psychiatry, DSM-IV codes

Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that company management will present and host one-on-one meetings during the Stifel 2024 Virtual CNS Days taking place March 19 to 20, 2024.

Key Points:

Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that company management will present and host one-on-one meetings during the Stifel 2024 Virtual CNS Days taking place March 19 to 20, 2024.
Shawn Singh, Chief Executive Officer, will participate in a fireside chat on Wednesday, March 20 at 12:00 p.m. Eastern Time.
A webcast will be accessible through the “ Events ” page in the “Investors” section of the Company’s website at www.Vistagen.com .
Investors interested in arranging a one-on-one meeting during the conference should contact their Stifel representative.

Essential Properties Realty Trust, Inc. Announces Pricing of Upsized Public Offering of Common Stock

Retrieved on:

Tuesday, March 12, 2024

Essential Properties Realty Trust, Inc. (NYSE: EPRT; the “Company”) announced today the pricing of an underwritten public offering of 9,000,000 shares of its common stock, all of which are being offered in connection with the forward sale agreements described below, at a public offering price of $24.75 per share.

Key Points:

Essential Properties Realty Trust, Inc. (NYSE: EPRT; the “Company”) announced today the pricing of an underwritten public offering of 9,000,000 shares of its common stock, all of which are being offered in connection with the forward sale agreements described below, at a public offering price of $24.75 per share.
The offering was upsized from the previously announced offering size of 8,000,000 shares of common stock, and the offering is expected to close on March 14, 2024, subject to customary closing conditions.
BofA Securities, Wells Fargo Securities, Truist Securities and Mizuho are acting as the joint book-running managers for the offering.
BMO Capital Markets, TD Securities, Barclays, Capital One Securities, Citigroup and Goldman Sachs & Co. LLC are acting as the book-running managers of the offering.

Parry Labs Names Mark Blanco as Chief Growth Officer

Retrieved on:

Monday, April 1, 2024

Mechanical, Stifel, Teledyne Technologies, Growth, Associate, Business, FLIR, Tuck School of Business, Sale, Dartmouth College, University, Private sector, Football, Creativity, Management

ALEXANDRIA, Va., April 1, 2024 /PRNewswire/ -- Today, Parry Labs LLC., a defense technology company developing next generation mission systems, officially announced the appointment of Mark Blanco as its Chief Growth Officer.

Key Points:

ALEXANDRIA, Va., April 1, 2024 /PRNewswire/ -- Today, Parry Labs LLC., a defense technology company developing next generation mission systems, officially announced the appointment of Mark Blanco as its Chief Growth Officer.
As Parry's Chief Growth Officer, he will be responsible for driving Parry's long-term strategy, leading strategic opportunities, and playing a pivotal role in establishing and nurturing customer relationships.
"We are delighted to have Mark join the Parry Labs team and bring his experience, creativity, and focus to the company," said Chief Executive Officer, John Parkes.
"I am extremely excited for the opportunity to help continue to drive the growth of the Parry Labs business, but more importantly support our customers and address the challenges they face today and in the future," said the new Chief Growth Officer, Mark Blanco.